Inhibiteur calcique (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inhibiteur calcique" in French language version.

refsWebsite

Global rank French rank

234^th place

147^th place

2ahajournals.org

3,608^th place

659^th place

low place

7,110^th place

1jamanetwork.com

2,650^th place

689^th place

274^th place

223^rd place

ahajournals.org

Plat F, Broughton A, Douville P, Sager PT, Soh B, Wight D, The electrocardiographic effects of intranasal formulations of a new calcium channel blocker, MSP-2017, are consistent with a potential treatment of paroxysmal supraventricular tachycardia: results of a phase 1 dose escalation study, Circulation, 2015;132:A19713
Stambler BS, Camm AJ, Alings M et al. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial, Lancet, 2023;402:118–28

cmaj.ca

(en) Wright AJ, Gomes T, Mamdani MM, Horn JR, Juurlink DN, « The risk of hypotension following coprescription of macrolide antibiotics and calcium-channel blockers » CMAJ 2011;183:303-307.

jamanetwork.com

archinte.jamanetwork.com

Li CI, Daling JR, Tang M-TC, Haugen KL, Parter PL, Malone KE, Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years, JAMA Intern Med, 2013;173:1629-1637

nature.com

(en) Jalava KM, Olkkola KT, Neuvonen PJ. « Itraconazole greatly increases plasma concentrations and effects of felodipine » Clin Pharmacol Ther. 1997;61:410-415.
(en) Glesby MJ, Aberg JA, Kendall MA. et al. « Pharmacokinetic interactions between indinavir plus ritonavir and calcium-channel blockers » Clin Pharmacol Ther. 2005;78:143-153.
(en) Bailey DG, Bend JR, Arnold JM, Tran T, Spence JD, « Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice » Clin Pharmacol Ther. 1996;60:25-33

springer.com

link.springer.com

Bailey DG, Dresser GK, Interactions between grapefruit juice and cardiovascular drugs, Am J Cardiovasc Drugs, 2004;4:281–297